CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CAPR on Nasdaq
Shares outstanding
51,786,227
Price per share
$23.62
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
27,422,288
Total reported value
$790,651,714
% of total 13F portfolios
0%
Share change
+12,611,171
Value change
+$390,644,574
Number of holders
132
Price from insider filings
$23.62
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUVRETTA CAPITAL MANAGEMENT, LLC 6.6% $80,730,585 3,417,891 SUVRETTA CAPITAL MANAGEMENT, LLC 19 Feb 2026
TANG CAPITAL MANAGEMENT LLC 6.6% $98,136,074 3,399,900 TANG CAPITAL MANAGEMENT, LLC 16 Jan 2026
BlackRock, Inc. 6.5% $38,658,889 2,966,914 BlackRock, Inc. 31 Dec 2024
VANGUARD GROUP INC 4.8% -4.4% $15,910,444 -$709,168 2,206,719 -4.3% The Vanguard Group 30 Sep 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2.3% $29,748,000 1,200,000 Highbridge Capital Management, LLC 31 Dec 2025

As of 31 Dec 2025, 132 institutional investors reported holding 27,422,288 shares of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR). This represents 53% of the company’s total 51,786,227 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) together control 44% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 5.5% 2,850,978 -0.67% 0% $82,279,225
VANGUARD GROUP INC 4.9% 2,561,880 +16% 0% $73,935,857
Point72 Asset Management, L.P. 3.6% 1,839,876 +1451% 0.08% $53,098,821
SUVRETTA CAPITAL MANAGEMENT, LLC 3.4% 1,785,610 1.3% $51,532,705
TANG CAPITAL MANAGEMENT LLC 3.3% 1,700,000 2.4% $49,062,000
RA CAPITAL MANAGEMENT, L.P. 2.9% 1,507,844 0.45% $43,516,378
GEODE CAPITAL MANAGEMENT, LLC 2% 1,017,332 +5.8% 0% $29,367,394
FMR LLC 1.8% 922,634 +3795% 0% $26,627,228
CITADEL ADVISORS LLC 1.7% 901,996 +499% 0.02% $26,031,604
STATE STREET CORP 1.6% 829,521 +3.5% 0% $23,939,976
Darwin Global Management, Ltd. 1.5% 800,000 0.47% $23,168,000
MILLENNIUM MANAGEMENT LLC 1.3% 682,344 +237% 0.01% $19,692,448
Soleus Capital Management, L.P. 1.2% 646,390 0.79% $18,654,815
J. Goldman & Co LP 1.1% 595,376 +24% 0.67% $17,182,551
MORGAN STANLEY 1.1% 585,840 +6.2% 0% $16,907,343
Ikarian Capital, LLC 1.1% 578,015 +118% 2.2% $16,681,512
GOLDMAN SACHS GROUP INC 0.87% 447,983 +155% 0% $12,928,789
DG Capital Management, LLC 0.8% 413,963 -12% 9.6% $11,946,972
SB Capital Management Inc 0.77% 400,001 0% 4.2% $11,544,028
JPMORGAN CHASE & CO 0.71% 369,134 +94% 0% $10,653,207
Balyasny Asset Management L.P. 0.68% 352,998 0.02% $10,187,522
NORTHERN TRUST CORP 0.68% 350,641 -0.53% 0% $10,119,500
Boxer Capital Management, LLC 0.63% 325,000 2.1% $9,379,500
RTW INVESTMENTS, LP 0.48% 250,000 0.07% $7,215,000
Quinn Opportunity Partners LLC 0.47% 242,883 +89% 0.3% $7,009,603

Institutional Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 27,422,288 $790,651,714 +$390,644,574 $28.86 132
2025 Q3 14,454,970 $104,098,244 +$3,052,263 $7.21 115
2025 Q2 13,740,752 $136,510,446 -$45,087,125 $9.93 105
2025 Q1 18,332,527 $174,018,005 +$4,472,871 $9.49 120
2024 Q4 17,327,955 $239,127,553 +$123,239,591 $13.80 107
2024 Q3 8,369,327 $127,297,422 +$33,779,392 $15.21 75
2024 Q2 6,426,234 $30,652,576 +$6,579,081 $4.77 60
2024 Q1 4,817,759 $32,711,658 +$5,474,658 $6.79 55
2023 Q4 4,019,035 $19,652,993 -$3,283,556 $4.89 37
2023 Q3 5,536,583 $18,934,429 +$9,929,580 $3.42 34
2023 Q2 2,624,364 $12,543,954 +$927,959 $4.78 32
2023 Q1 2,433,746 $10,269,762 -$1,225,035 $4.22 30
2022 Q4 2,739,017 $10,569,409 -$271,547 $3.86 31
2022 Q3 2,792,373 $16,752,192 +$1,609,613 $6.00 28
2022 Q2 2,543,515 $8,872,518 -$139,327 $3.49 27
2022 Q1 2,589,186 $8,879,200 +$964,475 $3.43 26
2021 Q4 2,320,262 $6,798,547 -$740,098 $2.93 24
2021 Q3 2,490,642 $10,025,330 -$5,545,456 $4.02 25
2021 Q2 3,528,427 $18,097,220 -$4,296,483 $5.13 26
2021 Q1 4,384,650 $20,517,844 +$13,558,859 $4.68 28
2020 Q4 1,499,334 $5,140,899 +$692,978 $3.43 24
2020 Q3 1,264,478 $6,640,688 +$1,920,376 $5.25 25
2020 Q2 940,377 $4,324,870 +$2,983,542 $4.60 30
2020 Q1 498,312 $597,000 +$332,841 $1.20 15
2019 Q4 214,939 $275,000 +$78,218 $1.29 11
2019 Q3 123,654 $459,000 +$151,133 $3.73 15
2019 Q2 84,706 $281,000 +$281,000 $3.33 10